NOVEOS, the solution to solid-phase related CCD interference

Updated: Sep 2, 2020

April 23, 2020 – GARDEN GROVE, CAL., Cross-reactive carbohydrate determinant (CCD) structures found in plant and insect glycoproteins are commonly recognized by IgE antibodies as epitopes that can lead to extensive cross-reactivity and obscure in vitro diagnostic (IVD) serology results. With the introduction of component resolved diagnosis (CRD), recombinant non-glycosylated components have been utilized to mitigate the risk of CCD-specific IgE (sIgE) detection. However, a recent study has shown that CCD-sIgE may bind directly to the cellulose solid-phase matrix used in certain in vitro diagnostic assays, eliminating the advantage of CRD over traditional extract-based testing. The aim of this study is to further investigate the prevalence of CCD-sIgE interference on a commonly-used in vitro sIgE automated platform which employs a cellulose-based matrix to immobilize CCD-free recombinant components. To check the complete article about CCD interferences follow the link here.

PLOS ONE CCD Publication April 23, 2020
Download • 1.69MB

Receive Notifications From HYCOR

  • LinkedIn

© 2021 HYCOR Biomedical  /  All Rights Reserved /  International Privacy  /  U.S Privacy  /